A case of severe cutaneous, GI and liver GVHD in a patient with multiple myeloma, status-post-second auto-SCT

Bone Marrow Transplantation

Volumn 45, Issue 2, 2010, Pages 409-411

  Goddard, D S ^a   Ruben, B S ^a   Mathes, E D ^a   Nixon, M ^a   Wolf, J ^a   Fox, L P ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; ANTIBIOTIC AGENT; BILIRUBIN; GAMMA GLUTAMYLTRANSFERASE; GANCICLOVIR; IMMUNOGLOBULIN; LENALIDOMIDE; VIRUS ANTIBODY;

ADULT; ALKALINE PHOSPHATASE BLOOD LEVEL; ANTIBIOTIC THERAPY; AUTOLOGOUS STEM CELL TRANSPLANTATION; BILIRUBIN BLOOD LEVEL; CANCER RELAPSE; CASE REPORT; COLON EDEMA; COLONOSCOPY; COMPUTER ASSISTED TOMOGRAPHY; CYTOMEGALOVIRUS INFECTION; DIARRHEA; DRUG TREATMENT FAILURE; EDEMA; ENTEROCOLITIS; FEMALE; FEVER; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GASTROINTESTINAL BIOPSY; GASTROINTESTINAL TRACT; GRAFT VERSUS HOST REACTION; HERPES SIMPLEX; HUMAN; HUMAN TISSUE; LETTER; LEUKOCYTOSIS; LIVER; LIVER BIOPSY; MULTIPLE MYELOMA; PANCYTOPENIA; PRIORITY JOURNAL; SKIN;

CYCLOSPORINE; FATAL OUTCOME; FEMALE; GASTROINTESTINAL DISEASES; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LIVER DISEASES; MIDDLE AGED; MULTIPLE MYELOMA; SKIN DISEASES; TRANSPLANTATION, AUTOLOGOUS;

EID: 76749154431     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2009.157     Document Type: Letter

References (10)

1. Drobyski WR, Hari P, Keever-Taylor C, Komorowski R, Grossman W. Severe autologous GVHD after hematopoietic progenitor cell transplantation for multiple myeloma. Bone Marrow Transplant 2008; 43: 169-177.
2. Sica S, Chiusolo P, Salutari P, Piccirillo N, Laurenti L, Sora F et al. Autologous graft-versus-host disease after CD34+- purified autologous peripheral blood progenitor cell transplantation. J Hematother Stem Cell Res 2000; 9: 375-379.
3. Hood AF, Vogelsang GB, Black LP, Farmer ER, Santos GW. Acute graft-vs-host disease. development following autologous and syngeneic bone marrow transplantation. Arch Dermatol 1987; 123: 745-750.
4. Holmberg L, Kikuchi K, Gooley TA, Adams KM, Hockenbery DM, Flowers ME et al. Gastrointestinal graft-versushost disease in recipients of autologous hematopoietic stem cells: incidence, risk factors, and outcome. Biol Blood Marrow Transplant 2006; 12: 226-234.
5. Tzung SP, Hackman RC, Hockenbery DM, Bensinger W, Schiffman K, McDonald GB. Lymphocytic gastritis resembling graft-vs.-host disease following autologous hematopoietic cell transplantation. Biol Blood Marrow Transplant 1998; 4: 43-48.
6. Saunders MD, Shulman HM, Murakami CS, Chauncey TR, Bensinger WI, McDonald GB. Bile duct apoptosis and cholestasis resembling acute graft-versus-host disease after autologous hematopoietic cell transplantation. Am J Surg Pathol 2000; 24: 1004-1008.
7. Kline J, van Besien K, Nathanson J, Noffsinger A, Artz A. Severe intestinal graft-versus-host disease following autologous stem cell transplantation. Bone Marrow Transplant 2006; 38: 391-392.
8. Appleton AL, Sviland L, Wilkes J, Pearson AD, Malcolm AJ. Late development of graft-versus-host disease in an autologous BMT recipient. Bone Marrow Transplant 1994; 13: 823-825.
9. Adams KM, Holmberg LA, Leisenring W, Fefer A, Guthrie KA, Tylee TS et al. Risk factors for syngeneic graft-versushost disease after adult hematopoietic cell transplantation. Blood 2004; 104: 1894-1897.
10. Latif T, Pohlman B, Kalaycio M, Sobecks R, Hsi ED, Andresen S et al. Syngeneic graft-versus-host disease: a report of two cases and literature review. Bone Marrow Transplant 2003; 32: 535-539.